Navigation Links
GENova Biotherapeutics signs collaboration agreement with Prime BioResearch
Date:9/15/2009

with significant growth potential. Prime BioResearch currently has a proprietary portfolio of six worldwide patents in Obesity and Diabetes-II with of $2.9 billion, if successfully brought through development, clinical trials, and to market (Source: PriceWaterhouseCoopers). The Company's mission is to make safe and effective drugs available to the public, quickly and at affordable levels.

About GENova Biotherapeutics Inc.

GENova is positioning itself as the world's leading bioscience company in the development and commercial licensing of novel therapeutic proteins that disrupt the advance of life-threatening cancers. The company leverages cutting-edge research collaborations to achieve breakthroughs in anti-cancer treatments, and then licenses these drug product candidates to Big Pharmaceutical and Biotechnology companies such as Pfizer, Amgen, Myriad Genetics, Medarex, and Biogen Idec. Visit GENova online at: www.genovabio.com.

Forward Looking Statements

This document includes certain statements that may be deemed to be "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact, are expected by the Company to be forward-looking statements. Although GENova believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in the forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include but are not limited to the success of the owned intellectual property, the strength of the patents, continued availability of capital and financing, and general economic market or business c
'/>"/>

SOURCE GENova Biotherapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. GENova Biotherapeutics and Prime BioResearch signs LOI on diabetes and cancer cure
2. GENova gains access to Big Pharma
3. GENova appoints Dr. Wang Chong to Scientific Advisory Board
4. GENova appoints Dr. Philip Gould to Scientific Advisory Board
5. GENova issues clarifying press release
6. GENova to acquire three new drug target patents worth in excess of $1 billion in royalty fees
7. GENova files patent for new breast cancer treatment
8. GENova appoints Director of Asian business development
9. GENova discusses development of new anti-cancer biotechs potentially worth $400 Million per annum
10. GENova appoints Dr. Anders Boegh Jensen to Scientific Advisory Board
11. Genova files patent for new prostate cancer treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... (PRWEB) August 20, 2014 Locating rates for ... of the Quotes Pros website. A new source of term ... and review rates good for all 50 states at ... is one of the new methods available for the public ... packages that are supplied. The instant quotations that are available ...
(Date:8/20/2014)... Thompson HealthDay Reporter WEDNESDAY, ... has saved a group of rhesus monkeys from deadly Marburg ... up to 90 percent of those it infects, researchers report. ... of Marburg virus, even when it was given three days ... the journal Science Translational Medicine . This is ...
(Date:8/20/2014)... An imaging study of chronic users of codeine-containing ... regions of brain white matter and associates these ... , Researchers used diffusuion tensor imaging (DTI) (an ... investigate the white matter integrity of chronic CCS ... the brain, including the inferior fronto-occipital fasciculus, which ...
(Date:8/20/2014)... Barbara Bronson Gray HealthDay Reporter ... extremely rare, colds, flu and other minor infections might ... stroke in children, a new study suggests. Just five ... the United States, said Dr. Heather Fullerton, lead author of ... the University of California, San Francisco Benioff Children,s Hospital. "It ...
(Date:8/20/2014)... HealthDay Reporter WEDNESDAY, Aug. 20, 2014 (HealthDay ... an option, but a new study shows that only about ... reasons women didn,t undergo reconstruction was that they felt it ... were focused on their cancer treatment," said lead researcher Dr. ... Cancer Center, in New York City. Also common was ...
Breaking Medicine News(10 mins):Health News:Term Life Insurance Price Database Now Helps Quote Prices for Adults in 50 States Online 2Health News:Drug for Ebola-Like Virus Shows Promise in Monkeys 2Health News:Drug for Ebola-Like Virus Shows Promise in Monkeys 3Health News:Study Ties Colds, Flu to Rare Risk of Stroke in Kids 2Health News:Study Ties Colds, Flu to Rare Risk of Stroke in Kids 3Health News:Many Women Who Have Mastectomy Don't Get Breast Reconstruction: Study 2Health News:Many Women Who Have Mastectomy Don't Get Breast Reconstruction: Study 3
... effect on someones physical health? This question is debated ... the latest Medical Journal of Australia. ,Spirituality ... spirituality in health, its relevance to Australian practitioners and ... and the current gaps where more research is needed. ...
... is needed to reduce the risk of diabetes in ... ,A study by Dr Robyn McDermott, Pro-vice Chancellor of ... South Australia, shows that while clinical care of adults ... the disease. ,The results, published in ...
... enough changes in the brain to sensitize people to ... , even in people who dont have a stress-related ... high-intensity traumas can have long lasting effects on the ... current clinical disorder. But these subtle changes could increase ...
... Q10 appear to increase blood levels of this ... , but does not improve Parkinsons disease ... is a neurodegenerative disorder characterized by tremors and ... mechanisms underlying the condition are not fully understood, ...
... has called upon the media to take message of environmental ... personal lives . ,Actoptrnot hit back at accusations ... and narrated at the Cannes film festival. ,Asked ... taken a fuel-guzzling jet on his way to the French ...
... that dissolves in the mouth like a popular breath-freshener ... impoverished areas. The innovative drug-delivery system was developed ... ,During a two-semester course, the seven-student team fabricated a ... mouth, prompting the child to swallow the vaccine. The ...
Cached Medicine News:Health News:Trauma Exposure can Affect Brain Function Several Years After Event 2Health News:Coenzyme Q10 Does Not Improve Parkinsons Disease Symptoms 2Health News:DiCaprio Bites Back Over Eco 'Hypocrisy' 2Health News:Students Devise Oral Quick-dissolve Strips for Rotavirus Vaccine 2Health News:Students Devise Oral Quick-dissolve Strips for Rotavirus Vaccine 3
(Date:8/20/2014)...   Easy Breathe , the fastest growing online sleep ... " - has received more than 4.5 million unique page views ... thrilled that so many people are finding our blog and reading ... "We,re committed to making sleep apnea more widely known and hope ... sleep apnea news , troubleshooting advice , and ...
(Date:8/20/2014)... NEW YORK , Aug. 20, 2014 /PRNewswire/ ... new market research report is available in its ... Electronic Medical Records http://www.reportlinker.com/p0833392/EMR-2014-The-Market-for-Electronic-Medical-Records.html ... fast-changing market for electronic medical records (EMR) for ... a comprehensive report of our findings. Our report ...
(Date:8/20/2014)... 20, 2014 Phase I Trial ... US  KalVista Pharmaceuticals ("KalVista"), an ophthalmology company ... announces that it has begun a Phase I, First ... KVD001, for the treatment of DME. The study,s Principal ... Eye Institute, Joslin Diabetes Center; Harvard Medical School Department ...
Breaking Medicine Technology:Easy Breathe Blog Emerges as the Go-To Resource for Sleep Apnea Sufferers 2Easy Breathe Blog Emerges as the Go-To Resource for Sleep Apnea Sufferers 3Easy Breathe Blog Emerges as the Go-To Resource for Sleep Apnea Sufferers 4EMR 2014: The Market for Electronic Medical Records 2EMR 2014: The Market for Electronic Medical Records 3EMR 2014: The Market for Electronic Medical Records 4EMR 2014: The Market for Electronic Medical Records 5EMR 2014: The Market for Electronic Medical Records 6EMR 2014: The Market for Electronic Medical Records 7EMR 2014: The Market for Electronic Medical Records 8KalVista Pharmaceuticals Announces Start of Clinical Development for Novel Treatment for Diabetic Macular Edema 2KalVista Pharmaceuticals Announces Start of Clinical Development for Novel Treatment for Diabetic Macular Edema 3KalVista Pharmaceuticals Announces Start of Clinical Development for Novel Treatment for Diabetic Macular Edema 4
... Galleon Pharmaceuticals, a leader in the pharmaceutical treatment of ... has elected Thomas J. Dietz, Ph.D., as the company,s ... Holdings, LLC, a diversified financial-holdings and services company.   ... then CEO and a director of Pacific Growth Equities, ...
... Reportlinker.com announces that a new market ... Medical Imaging Markets: Contrast ... The application and versatility of ... in significance as the population ages and ...
Cached Medicine Technology:Thomas Dietz, Ph.D., Elected Chairman of Galleon Pharmaceuticals 2Medical Imaging Markets: Contrast Agents 2Medical Imaging Markets: Contrast Agents 3Medical Imaging Markets: Contrast Agents 4Medical Imaging Markets: Contrast Agents 5Medical Imaging Markets: Contrast Agents 6
... UroVysion Bladder Cancer Kit (UroVysion Kit) is designed ... and loss of the 9p21 locus via fluorescence ... persons with hematuria suspected of having bladder cancer. ... use, in conjunction with and not in lieu ...
A Powerful New Quantitative Immunoassay for Monitoring Bladder Cancer Patients. Useful in Monitoring Patients for,Disease Progression and Recurrence....
ARION is a long-pulsed alexandrite laser system with a wavelength of 755 nm...
... Used to connect ... an infusion pump, and ... catheter in order to ... use with Laborie Medical ...
Medicine Products: